Show simple item record

Salvage bacteriophage therapy for a chronic MRSA prosthetic joint infection

dc.contributor.authorDoub, J.B.
dc.contributor.authorNg, V.Y.
dc.contributor.authorJohnson, A.J.
dc.contributor.authorSlomka, M.
dc.date.accessioned2020-06-08T20:21:01Z
dc.date.available2020-06-08T20:21:01Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85085310608&doi=10.3390%2fantibiotics9050241&partnerID=40&md5=7e8d9a46f6a8c01ff1ca10deb82894fc
dc.identifier.urihttp://hdl.handle.net/10713/12990
dc.description.abstractThis is a case of a 72 year old male with a chronic methicillin-resistant Staphylococcus aureus prosthetic joint infection. After the third intravenous dose of bacteriophage therapy, an unusual, reversible transaminitis prompted stoppage of bacteriophage therapy. Nevertheless, treatment was successful and the patient's severe chronic infection was eradicated. Copyright 2020 by the authors.en_US
dc.description.urihttp://doi.org/10.3390/antibiotics9050241en_US
dc.language.isoen_USen_US
dc.publisherMDPI AGen_US
dc.relation.ispartofAntibiotics
dc.subjectBacteriophage therapyen_US
dc.subjectBiofilmen_US
dc.subjectMedication induced hepatitisen_US
dc.subjectMethicillin resistance Staphylococcus aureusen_US
dc.subjectProsthetic joint infectionen_US
dc.titleSalvage bacteriophage therapy for a chronic MRSA prosthetic joint infectionen_US
dc.typeArticleen_US
dc.identifier.doi10.3390/antibiotics9050241


This item appears in the following Collection(s)

Show simple item record